VistaGen Therapeutics Inc (NASDAQ:VTGN)

0.80
Delayed Data
As of Aug 03
 -0.125 / -13.44%
Today’s Change
0.29
Today|||52-Week Range
1.49
+15.99%
Year-to-Date
VistaGen under pressure on proposed public offering
Jul 31 / Seeking Alpha - Paid Partner Content
IPO Update: Vasta Platform Pursues $306 Million U.S. IPO
Jul 27 / Seeking Alpha - Paid Partner Content
VistaGen readies equity offering
Jul 31 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close0.93
Today’s open0.78
Day’s range0.76 - 0.82
Volume4,761,271
Average volume (3 months)1,312,578
Market cap$52.2M
Data as of 3:59pm ET, 08/03/2020

Growth & Valuation

Earnings growth (last year)+44.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CDMOPAvid Bioservices Inc-0.17-0.68%
MBOTMicrobot Medical Inc+0.17+2.53%
SEELSeelos Therapeutics ...-0.07-6.03%
IMMPImmutep Ltd-0.06-4.48%
Data as of 3:59pm ET, 08/03/2020

Financials

Next reporting dateAugust 18, 2020
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$20.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts